KRAS and neoplasm: These variables include age, diameter of the largest CRLM tumor, number of tumors, carcinoembryonic antigen (CEA) level, T category of the primary tumor, primary lymph node involvement, primary tumor side, presence of extrahepatic disease, surgical margin status, and KRAS mutational status.